Study sheds more light on rate of rare blood clots after Oxford-AstraZeneca vaccine

A large study from Denmark and Norway published by The BMJ today sheds more light on the risk of rare blood clots in adults receiving their first dose of the Oxford-AstraZeneca COVID-19 vaccine.